Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression

Sasaki,Shuji; Yashima,Kazuo; Hayashi,Akihiro; Takeda,Yohei; Yasugi,Akiko; Koda,Masaharu; Kawaguchi,Koichiro; Harada,Kenichi; Ito,Hisao; Murawaki,Yoshikazu

doi:10.3892/ol.2010.231

Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression

Authors:
- Shuji Sasaki
- Kazuo Yashima
- Akihiro Hayashi
- Yohei Takeda
- Akiko Yasugi
- Masaharu Koda
- Koichiro Kawaguchi
- Kenichi Harada
- Hisao Ito
- Yoshikazu Murawaki
View Affiliations

Affiliations: Division of Medicine and Clinical Science, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan, Division of Medicine and Clinical Science, Faculty of Medicine, Tottori University, 36-1 Nishicho, Yonago 683-8504, Japan
Published online on: December 30, 2010 https://doi.org/10.3892/ol.2010.231
Pages: 217-222

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypermethylation of the promoter region of the MLH1 gene leads to loss of Mlh1 protein expression and plays a key role in the development of gastric cancer. Little is known about the association between Mlh1 expression and the clinicopathological and patient characteristics in early gastric neoplasia, particularly in endoscopically resected tumors. Immunohistochemistry was used to examine Mlh1 expression in 140 early gastric neoplasias obtained by endoscopic resection and comprising 31 gastric adenomas (GAs) and 109 early gastric cancers (EGCs), and compared them to corresponding clinicopathological and patient data. P53 expression and phenotypic profiles were also analyzed. The rate of reduced Mlh1 expression and P53 overexpression was 9.6 and 6.5% in GAs, and 27.5 and 27.5% in EGCs, respectively. In elderly patients (≥65 years of age), the aberrant expression of Mlh1 in EGCs was more significant in female than in male patients (59.9 vs. 29.8%; P=0.016). In addition, the frequency of aberrant Mlh1 expression in EGCs increased significantly in patients with oncological family histories and elevated gross type (P=0.033 and P=0.04, respectively). Moreover, a significant correlation was observed among aberrant Mlh1, P53-negative and HGM expression. The present findings suggest that loss of Mlh1 expression is associated with age, gender, oncological family history and tumor growth pattern in EGC. Patient and tumor characteristics are key factors in the screening, surveillance and diagnosis of early gastric neoplasia, particularly in elderly individuals.

View Figures

View References

1	Parkin DM: International variation. Oncogene. 23:6329–6340. 2004. View Article : Google Scholar
2	Parkin DM, Brey F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar
3	Arai T, Esaki Y, Inoshita N, et al: Pathologic characteristics of gastric cancer in the elderly: a retrospective study of 994 surgical patients. Gastric Cancer. 7:154–159. 2004. View Article : Google Scholar : PubMed/NCBI
4	Eslick GD: Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence. World J Gastroenterol. 21:2991–2999. 2006.
5	Berinini M, Barbi S, Roviello F, et al: Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. Gastric Cancer. 9:9–13. 2006. View Article : Google Scholar : PubMed/NCBI
6	Kawasaki K, Kanemitsu K, Yasuda T, et al: Family history of cancer in Japanese gastric cancer patients. Gastric Cancer. 10:173–175. 2007. View Article : Google Scholar : PubMed/NCBI
7	World Cancer Research Fund, American Institute for Cancer Research, Food, Nutrition, Physical Activity and Prevention of Cancer. A Global Perspective. AICR; 2007
8	Jemal A, Clegg LX, Ward E, et al: Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 101:3–27. 2004.
9	Arai T and Takubo K: Clinicopathologicalal and molecular characteristics of gastric and colorectal carcinomas in the elderly. Pathol Int. 57:303–314. 2007. View Article : Google Scholar : PubMed/NCBI
10	Yashima K, Sasaki S, Koda M, Kawaguchi K, Harada K and Murawaki Y: Premalignant lesions in gastric cancer. Clin J Gastroenterol. 3:6–12. 2010. View Article : Google Scholar
11	Koseki K, Takizawa T, Koike M, Ito M, Nihei Z and Sugihara K: Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 89:724–732. 2000. View Article : Google Scholar : PubMed/NCBI
12	Tamura G: Alteration of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol. 14:192–198. 2006.PubMed/NCBI
13	Hong SH, Kim HG, Chung WB, et al: DNA hypermethylation of tumor-related genes in gastric carcinoma. J Korean Med Sci. 20:236–241. 2005. View Article : Google Scholar : PubMed/NCBI
14	Maesawa C, Tamura G, Suzuki Y, Ogasawara, Sakata K, Kashiwaba M and Satodate R: The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol. 176:249–258. 1995. View Article : Google Scholar
15	Yamazaki K, Tajima Y, Makino R, et al: Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastrenterol. 28:3803–3809. 2006.PubMed/NCBI
16	Fleisher AS, Esteller M, Wang S, et al: Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 59:1090–1095. 1999.PubMed/NCBI
17	Fleisher AS, Esteller M, Tamura G, et al: Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene. 20:329–335. 2001. View Article : Google Scholar : PubMed/NCBI
18	Nakajima T, Akiyama Y, Shiraishi J, et al: Age-related hypermethylation of the hMLH1 promoter in gastric cancers. Int J Cancer. 94:208–211. 2001. View Article : Google Scholar : PubMed/NCBI
19	Kim HG, Lee S, Kim DY, et al: Aberrant methylation of DNA mismatch repair genes in elderly patients with sporadic gastric carcinoma: a comparison with younger patients. J Surg Oncol. 101:28–35. 2010. View Article : Google Scholar : PubMed/NCBI
20	Ceccarelli M, Sera F, Costantini RM, Nesi G, Palli D and Ottini L: Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features and long-term survival. Hum Path. 39:925–932. 2008. View Article : Google Scholar
21	Baylin SB and Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
22	Egashira Y, Shimoda T and Ikegami M: Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int. 49:55–61. 1999. View Article : Google Scholar : PubMed/NCBI
23	Yoshino T, Shimoda T, Saito A, Nakanishi Y, Tajima Y, Shirasu T and Miura S: Macroscopic features of differentiated adenocarcinoma with gastric or intestinal phenotype expression in early gastric cancer. Stomach Intestine. 34:513–525. 1999.
24	Koseki K, Takizawa T, Koike M, Ito M, Nihei Z and Sugihara K: Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 89:724–732. 2000. View Article : Google Scholar : PubMed/NCBI
25	Koseki K, Takizawa T, Koike M, et al: Subclassification of well-differentiated gastric cancer with reference to biological behavior and malignancy, gastric type vs. intestinal type, and papillary carcinoma vs tubular carcinoma. Stomach Intestine. 34:507–512. 1999.
26	Endoh Y, Tamura G, Sakata K, et al: Genetic analysis of differentiated-type adenocarcinomas of the stomach with gastric phenotype and intestinal phenotype. Stomach Intestine. 34:539–544. 1999.
27	Tajima Y, Shimoda T, Nakanishi Y, et al: Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 61:212–220. 2001. View Article : Google Scholar
28	Kabashima A, Yao T, Sugimachi K and Tsuneyoshi M: Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinoma. Hum Pathol. 33:80–86. 2002. View Article : Google Scholar : PubMed/NCBI
29	Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer. 1:10–24. 1998. View Article : Google Scholar : PubMed/NCBI
30	Schlemper RJ, Riddell RH, Kato Y, et al: The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 47:251–255. 2000. View Article : Google Scholar : PubMed/NCBI
31	Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R and Ruschoff J: Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 57:4749–4756. 1997.PubMed/NCBI
32	Mizoshita T, Tsukamoto T, Cao X, et al: Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype. Gastric Cancer. 8:164–172. 2005. View Article : Google Scholar : PubMed/NCBI
33	Thibodeau SN, French AJ, Cunningham JM, et al: Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 58:1713–1718. 1998.PubMed/NCBI
34	Chaves P, Cruz C, Lage P, Claro I, Cravo M, Leitao CN and Soares J: Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol. 191:355–360. 2000. View Article : Google Scholar : PubMed/NCBI
35	Breivik J, Lothe RA, Meling GI, et al: Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer. 74:664–669. 1997. View Article : Google Scholar : PubMed/NCBI
36	French AJ, Petroni G, Thibideau SN, et al: Allelic imbalance of 8p indicates poor survival in gastric cancer. J Mol Diagn. 6:243–253. 2004. View Article : Google Scholar : PubMed/NCBI
37	Beghelli S, Manzoni G, Barbi S, et al: Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery. 139:347–356. 2006. View Article : Google Scholar : PubMed/NCBI
38	Schwartz AG, Whitcomb JM, Nyce JW, Lewbart ML and Pashko LL: Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents. Adv Cancer Res. 51:391–424. 1988. View Article : Google Scholar : PubMed/NCBI
39	Keller G, Rotter M, Vogelsang H, et al: Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. relation to clinicopathologicalal data and family history. Am J Pathol. 147:593–600. 1995.PubMed/NCBI
40	Shinmura K, Yin W, Isogaki J, et al: Stage-dependent evaluation of microsatellite instability in gastric carcinoma with familial clustering. Cancer Epidemiol Biomarkers Prev. 6:693–697. 1997.PubMed/NCBI
41	Ottini L, Palli D, Falchetti M, et al: Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res. 57:4523–4529. 1997.PubMed/NCBI
42	Kanemitsu K, Kawasaki K, Nakamura M, et al: MSI is frequently recognized among gastric cancer patients with a family history of cancer. Hepatogastroenterology. 54:2410–2414. 2007.PubMed/NCBI
43	Pedrazzani C, Corso G, Velho S, et al: Evidence of tumor microsatellite instability in gastric cancer with familial aggregation. Familial Cancer. 8:215–220. 2009. View Article : Google Scholar : PubMed/NCBI
44	Hara A, Yashima K, Yasugi A, et al: Expression of Fhit, Mlh1, p16^INK4A and E-cadherin in early gastric neoplasia: Correlation with histological grade and gastric phenotype. Oncol Rep. 18:553–559. 2007.PubMed/NCBI
45	Martinez R, Schackert HK, Plaschke J, Baretton G, Appelt H and Schackert G: Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme. Oncology. 66:395–403. 2004. View Article : Google Scholar : PubMed/NCBI
46	Matsumoto Y, Marusawa H, Kinoshita K, et al: Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 13:470–476. 2007. View Article : Google Scholar